These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 34680546)

  • 1. Type 2 Diabetes Mellitus and Cancer: Epidemiology, Physiopathology and Prevention.
    Rey-Reñones C; Baena-Díez JM; Aguilar-Palacio I; Miquel C; Grau M
    Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].
    Flórez H
    Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diabetes and cancer risk: oncologic considerations].
    Rosta A
    Orv Hetil; 2011 Jul; 152(29):1144-55. PubMed ID: 21712179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Polish Multicenter Study on Diabetes Epidemiology (PMSDE)--1998-2000].
    Szybiński Z
    Pol Arch Med Wewn; 2001 Sep; 106(3):751-8. PubMed ID: 11928582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 2 diabetes mellitus in children and adolescents: a review from a European perspective.
    Kiess W; Böttner A; Raile K; Kapellen T; Müller G; Galler A; Paschke R; Wabitsch M
    Horm Res; 2003; 59 Suppl 1():77-84. PubMed ID: 12566725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward practical prevention of type 2 diabetes.
    McCarty MF
    Med Hypotheses; 2000 May; 54(5):786-93. PubMed ID: 10859688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes mellitus in Bahrain: an overview.
    Musaiger AO
    Diabet Med; 1992 Jul; 9(6):574-8. PubMed ID: 1643809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the effects of thiazolidinediones and metformin on metabolic control in patients with type 2 diabetes mellitus.
    Seufert J; Lübben G; Dietrich K; Bates PC
    Clin Ther; 2004 Jun; 26(6):805-18. PubMed ID: 15262452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.
    Avenell A; Broom J; Brown TJ; Poobalan A; Aucott L; Stearns SC; Smith WC; Jung RT; Campbell MK; Grant AM
    Health Technol Assess; 2004 May; 8(21):iii-iv, 1-182. PubMed ID: 15147610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of type 2 diabetes.
    Lai LC
    Malays J Pathol; 2002 Dec; 24(2):71-6. PubMed ID: 12887163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and diabetes epidemics: cancer repercussions.
    Hjartåker A; Langseth H; Weiderpass E
    Adv Exp Med Biol; 2008; 630():72-93. PubMed ID: 18637486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin monotherapy for type 2 diabetes mellitus.
    Saenz A; Fernandez-Esteban I; Mataix A; Ausejo M; Roque M; Moher D
    Cochrane Database Syst Rev; 2005 Jul; (3):CD002966. PubMed ID: 16034881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic prevention or delay of type 2 diabetes mellitus.
    Anderson DC
    Ann Pharmacother; 2005 Jan; 39(1):102-9. PubMed ID: 15562143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epidemiology and molecular mechanisms linking obesity, diabetes, and cancer.
    Ferguson RD; Gallagher EJ; Scheinman EJ; Damouni R; LeRoith D
    Vitam Horm; 2013; 93():51-98. PubMed ID: 23810003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug administration in patients with diabetes mellitus. Safety considerations.
    Gilbert RE; Cooper ME; Krum H
    Drug Saf; 1998 Jun; 18(6):441-55. PubMed ID: 9638389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of programmes as part of primary prevention demonstrated on the example of cardiovascular diseases and the metabolic syndrome.
    Korczak D; Dietl M; Steinhauser G
    GMS Health Technol Assess; 2011 Apr; 7():Doc02. PubMed ID: 21468290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes.
    Viberti G; Kahn SE; Greene DA; Herman WH; Zinman B; Holman RR; Haffner SM; Levy D; Lachin JM; Berry RA; Heise MA; Jones NP; Freed MI
    Diabetes Care; 2002 Oct; 25(10):1737-43. PubMed ID: 12351470
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.